Acadian Asset Management LLC Ocuphire Pharma, Inc. Transaction History

Acadian Asset Management LLC

  • $32.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$3.35 - $4.33 $71,415 - $92,306
21,318 Added 75.48%
49,563 $165,000
Q2 2023

Aug 07, 2023
BUY
$3.63 - $6.38 $102,529 - $180,203
28,245 New
28,245 $122,000
Q2 2021

Aug 11, 2021
SELL
$4.24 - $6.57 $9,217 - $14,283
-2,174 Closed
0 $0
Q1 2021

May 11, 2021
BUY
$5.7 - $13.31 $12,391 - $28,935
2,174 New
2,174 $13,000

Others Institutions Holding OCUP

# of Institutions
43
Shares Held
2.58M
Call Options Held
14.1K
Put Options Held
800
View Full List

About Ocuphire Pharma, Inc.

OCUP Quotes by TradingView
  • Ticker OCUP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,579,800
  • Market Cap $20.2M
  • Description
  • Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...
More about OCUP
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email